Article Details

New Phase 1/2 EXPLORE44 Trial Data Shows Continued Treatment Effect of AOC 1044 in ...

Retrieved on: 2024-08-13 18:31:56

Tags for this article:

Click the tags to see associated articles and topics

New Phase 1/2 EXPLORE44 Trial Data Shows Continued Treatment Effect of AOC 1044 in .... View article details on hiswai:

Excerpt

AOC 1044, a nonapproved treatment designed to deliver PMO to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene to ...

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up